Beyond, INC Schedule 13G passive stakes

Morgan Stanley has reported a decrease in its beneficial ownership of Bed Bath & Beyond, Inc. common stock to 5.4%.

Mitchell and Sharon Rosen, along with their associated trusts, have disclosed a combined beneficial ownership of 7,200,000 shares, representing 8.9% of Bed Bath & Beyond's common stock.

A joint filing reveals Mitchell A. Rosen, Sharon Rosen, and associated trusts now collectively hold 8.9% of Bed Bath & Beyond's common stock.

Amplify Investments and Amplify ETF Trust have jointly reported beneficial ownership of 9.4% of Bed Bath & Beyond's common stock as of June 30, 2026.

Amplify Investments LLC and Amplify ETF Trust have jointly filed a Schedule 13G, reporting beneficial ownership of 10.7% of Bed Bath & Beyond's common stock as of May 31, 2026.

Amplify Investments LLC and Amplify ETF Trust have jointly filed a Schedule 13G, reporting beneficial ownership of 8.7% of Bed Bath & Beyond, Inc. common stock as of March 31, 2026.

Vanguard Capital Management has reported beneficial ownership of 5.01% of Bed Bath & Beyond Inc.'s common stock as of March 31, 2026.

The Vanguard Group reports 0% beneficial ownership in Bed Bath & Beyond Inc. following an internal realignment, with subsidiaries now reporting separately.

Amplify ETF Trust, through its Amplify Blockchain Technology ETF, reported an 8.27% beneficial ownership stake in Bed Bath & Beyond, Inc. common stock.

Amplify Blockchain Technology ETF, formerly Amplify Transformational Data Sharing ETF, filed an amendment to its Schedule 13G, disclosing ownership of 5% or less of Bed Bath & Beyond Inc. common stock.

Jane Street Group, LLC and its affiliates reported a 1.6% beneficial ownership stake in Bed Bath & Beyond, Inc. common stock as of December 31, 2025.

The Vanguard Group has filed an amended Schedule 13G, disclosing a 7.62% beneficial ownership stake in Bed Bath & Beyond Inc., primarily in the form of warrants.

Amplify Transformational Data Sharing ETF has reported a 6.53% beneficial ownership stake in Bed Bath & Beyond Inc. common stock.

The Vanguard Group filed an amended Schedule 13G, disclosing its passive beneficial ownership of 6.5% of Bed Bath & Beyond Inc.'s common stock.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.2% beneficial ownership stake in Bed Bath & Beyond, Inc. as of September 30, 2025.

Jane Street Group, LLC and its affiliates have reported a 5.1% beneficial ownership stake in Bed Bath & Beyond, Inc. common stock.

The Vanguard Group has reported a passive beneficial ownership of 5.22% in Beyond Inc., holding over 3 million shares of common stock.

Morgan Stanley has filed an amended Schedule 13G, disclosing that its beneficial ownership in Beyond, Inc. has decreased to 3.5% of common stock, falling below the 5% reporting threshold.

The Vanguard Group has filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.94% in Beyond Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, confirming a 5.8% passive beneficial ownership in BEYOND INC as of March 31, 2025.

Amplify Transformational Data Sharing ETF, a series of the Amplify ETF Trust, has reported a passive 5.22% ownership stake in BEYOND, INC. as of December 31, 2024.

Morgan Stanley has filed a Schedule 13G, revealing a passive beneficial ownership of 6.1% of BEYOND, INC.'s common stock as of December 31, 2024.

The Vanguard Group has filed an amended Schedule 13G, reporting a passive beneficial ownership of 5.53% in Beyond Inc.'s common stock as of December 31, 2024.